Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Valproate in Late Life Schizophrenia
NCT00194025Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Nov 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of divalproex sodium in schizophrenia, sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Positive and Negative Symptom Scale at 12 weeks. Started Nov 2004; status: completed.
02
Drugs
divalproex sodium
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00194025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194025.